C. Ying

发表

Evolution of Drug-resistant Acinetobacter baumannii After DCD Renal Transplantation

Yuchen Wang, Yonghong Xiao, Junwen Wang, 2017, Scientific Reports.

Simulating moxalactam dosage for extended-spectrum β-lactamase-producing Enterobacteriaceae using blood antimicrobial surveillance network data

Yonghong Xiao, C. Ying, Hui Wang, 2019, Infection and drug resistance.

Blood bacterial resistant investigation collaborative system (BRICS) report: a national surveillance in China from 2014 to 2019

Qing Yang, C. Ying, Yiqun Liao, 2022, Antimicrobial resistance and infection control.

In Vitro Activity Comparison of Ceftazidime–Avibactam and Aztreonam–Avibactam Against Bloodstream Infections With Carbapenem-Resistant Organisms in China

Yonghong Xiao, C. Ying, Yunbo Chen, 2021, Frontiers in Cellular and Infection Microbiology.

Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation

Yonghong Xiao, C. Ying, Xin Zhou, 2021, Drug design, development and therapy.

Antibacterial Activity and Optimal Treatment of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae

Yonghong Xiao, Y. Qiu, C. Ying, 2021, Frontiers in Pharmacology.

Analysis of Genetic Diversity and Antibiotic Options for Clinical Listeria monocytogenes Infections in China

Y. Qiu, C. Ying, Yanzi Zhou, 2021, Open forum infectious diseases.

Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation

Yonghong Xiao, C. Ying, P. Shen, 2017, Drug design, development and therapy.

Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016

Yonghong Xiao, C. Ying, P. Shen, 2019, Antimicrobial Resistance & Infection Control.

Coexistence of NDM-1-producing Escherichia coli and Citrobacter freundii in the same patient.

J. Ying, C. Ying, Hao Xu, 2018, Journal of global antimicrobial resistance.

Population genomics of emerging Elizabethkingia anophelis pathogens reveals potential outbreak and rapid global dissemination

C. Ying, B. Zheng, Hao Xu, 2022, Emerging microbes & infections.

The Monte Carlo Simulation of Three Antimicrobials for Empiric Treatment of Adult Bloodstream Infections With Carbapenem-Resistant Enterobacterales in China

Yonghong Xiao, C. Ying, Chengwu Shen, 2021, Frontiers in Microbiology.

Emergence of Raoultella ornithinolytica Coproducing IMP-4 and KPC-2 Carbapenemases in China

Yonghong Xiao, Lanjuan Li, C. Ying, 2015, Antimicrobial Agents and Chemotherapy.

Genomic and phenotypic diversity of carbapenemase-producing enterobacteriaceae isolates from bacteremia in china: A multicenter epidemiological, microbiological, and genetic study

Yonghong Xiao, C. Ying, B. Zheng, 2020 .

Genome characterization of two bile-isolated Vibrio fluvialis strains: an insight into pathogenicity and bile salt adaption

Yonghong Xiao, Lanjuan Li, C. Ying, 2017, Scientific Reports.

Genome sequence of Shigella flexneri strain SP1, a diarrheal isolate that encodes an extended-spectrum β-lactamase (ESBL)

Yonghong Xiao, C. Ying, B. Zheng, 2017, Annals of Clinical Microbiology and Antimicrobials.

Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia: a retrospective study from 2013 to 2016

Yonghong Xiao, C. Ying, P. Shen, 2019, Antimicrobial Resistance & Infection Control.

Identification and Characterization of OXA-232-Producing Sequence Type 231 Multidrug Resistant Klebsiella pneumoniae Strains Causing Bloodstream Infections in China

C. Ying, K. Zhou, Hao Xu, 2023, Microbiology spectrum.

Blood bacterial resistant investigation collaborative system (BRICS) report: a national surveillance in China from 2014 to 2019

Qing Yang, C. Ying, Yunbo Chen, 2022, Antimicrobial resistance and infection control.

Cefepime, not Piperacillin/Tazobactam Use, for Empirical Treatment of Bloodstream Infections Caused by Enterobacter spp.: Results from a Population Pharmacokinetic/Pharmacodynamic Analysis.

C. Ying, Chen Huang, J. Ji, 2022, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evolution of Drug-resistant Acinetobacter baumannii After DCD Renal Transplantation

Yuchen Wang, Yonghong Xiao, Junwen Wang, 2017, Scientific Reports.

Evaluation of Piperacillin/Sulbactam, Piperacillin/Tazobactam and Cefoperazone/Sulbactam Dosages in Gram-Negative Bacterial Bloodstream Infections by Monte Carlo Simulation

C. Ying, Yunbo Chen, Chen Huang, 2023, Antibiotics.

Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China

Yonghong Xiao, Xin Wu, C. Ying, 2021, Drug design, development and therapy.

The professional status of infectious disease physicians in China: a nationwide cross-sectional survey.

Chao Zhang, C. Ying, S. Li, 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Determining optimal dosing regimen of oral administration of dicloxacillin using Monte carlo simulation

C. Ying, J. Ji, Tingting Xiao, 2017 .

Genome sequence of Shigella flexneri strain SP1, a diarrheal isolate that encodes an extended-spectrum β-lactamase (ESBL)

Yonghong Xiao, C. Ying, B. Zheng, 2017, Annals of Clinical Microbiology and Antimicrobials.

ESKAPE in China: epidemiology and characteristics of antibiotic resistance

C. Ying, B. Zheng, P. Shen, 2024, Emerging microbes & infections.